ADD A CATEGORY
JUL 24, 2013 - Benzinga
A Must Read - Share
In a report published Wednesday, Cantor Fitzgerald analyst Irina Rivkind upgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Sell to Hold, and raised the price target from $7.00 to $10.00.
Hey you have no friends!!! Get to work and start inviting friends to help build your Comunitee. Click Here to invite friends.
© 2011 Comunitee, Inc.